Will BETA's G&A exceed 40% of total operating expenses in any quarter of FY2026?

FY2025 G&A was 35% of OpEx. To exceed 40%, G&A would need to grow faster than R&D. But R&D is likely to accelerate in FY2026 as certification activities intensify (engine testing, CTOL production, VTOL development). The G&A increase in FY2025 was driven by one-time IPO costs (D&O insurance setup, initial compliance, banking fees) that should stabilize. Even if G&A stays at the $138.5M annual rate, R&D growth of 15-20% would increase the denominator, reducing G&A's share below 35%. The 40% threshold would require either G&A continuing to surge or R&D declining — both are unlikely.

The question asks about ANY quarter exceeding 40%. Quarterly G&A can be lumpy — insurance renewals, audit fees, legal costs cluster in specific quarters. A single quarter could spike to 40%+ even if the annual average is lower. However, R&D spending is also lumpy (milestone payments, testing campaigns). The structural trend — R&D growing 26% vs G&A growing 82% — included IPO transition costs that should normalize. In FY2026, G&A growth should moderate significantly while R&D continues expanding. A single quarter exceeding 40% is possible but unlikely.

Historical trajectory: G&A went from 27% of OpEx in FY2024 to 35% in FY2025, an 8pp increase driven by IPO costs. For it to reach 40%, G&A would need to increase another 5pp. Given that the IPO cost increase was a step-function (not ongoing), and R&D is the larger and growing cost item, a further increase to 40% requires a structural change in cost composition. The most likely scenario is G&A stabilizing at 33-36% as one-time costs normalize. Below 30% probability.

Public company costs have a high fixed component — D&O insurance, audit, compliance, IR. These tend to be front-loaded in year 1 and then stabilize. FY2025 was BETA's first year as a public company. The typical pattern is G&A spike in year 1, stabilize in year 2. Meanwhile, R&D will grow as certification activities ramp up. The 40% threshold is well above the current 35% and would require an unusual cost dynamic. Probability below 30%.

Consider that BETA is expanding internationally (Abu Dhabi, multiple countries), building out defense programs, and scaling the charging network — all of which have G&A components (international offices, compliance, contract administration). These are not one-time IPO costs but structural expansion costs. If international and defense G&A grows while R&D spending on CTOL/VTOL is back-end loaded in FY2026, a single quarter could see G&A at 40%+. Not the base case but plausible.

The most likely outcome is G&A stabilizing at the FY2025 rate ($138.5M annual or ~$35M/quarter) while R&D grows to ~$280-300M annual (~$70-75M/quarter). At $35M/($35M+$70M) = 33% — actually declining from 35%. To hit 40% in any quarter, G&A would need to be ~$47M against $70M R&D — a 34% increase from FY2025 quarterly average. This would require significant unplanned spending. Probability around 28%.

G&A typically stabilizes after first public year. R&D growth increases denominator. 40% threshold unlikely. Below 30%.

International expansion could add G&A costs. Quarterly lumpiness could create a single quarter spike. But R&D growth should dominate. Around 30%.

Post-IPO cost normalization and R&D growth make exceeding 40% unlikely. The structural trend favors declining G&A share. Below 30%.